Literature DB >> 11757338

Early and long-term results of coronary artery bypass grafting in dialysis patients.

S Suehiro1, T Shibata, K Hattori, H Hirai, H Fujii, N Aoyama, T Ikuta, M Sakaguchi, H Kinoshita.   

Abstract

OBJECTIVE: We evaluated the surgical outcome of coronary artery bypass grafting in dialysis patients.
METHODS: We retrospectively analyzed 25 consecutive dialysis patients requiring isolated coronary artery bypass grafting. Their mean age was 61.6 years and average dialysis duration 80.4 months.
RESULTS: Eight patients (32%) had emergency or urgent surgery. The mean number of bypassed vessels was 3.3 +/- 1.2. Internal thoracic artery grafts were used in 19 patients and gastroepiploic artery grafts in 5. Two (8%) died during hospitalization and complications occurred in 11 (44%). No cerebral complications were observed. All survivors showed ameliorated symptoms and improved overall function. Of 14 late deaths, 5 were cardiac-related, with 2 involving obvious myocardial ischemic events. Actuarial survival, including hospital deaths, at 1 year was 70.9%, at 3 years was 43.5%, and at 5 years was 34.8%. Cardiac-death-free survival was 70.2% at 3 years and 70.2% at 5 years.
CONCLUSION: Coronary artery bypass grafting in dialysis patients is associated with a higher incidence of complications but has acceptable surgical mortality and effectively relieves angina symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11757338     DOI: 10.1007/bf02912475

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  16 in total

1.  Cardiovascular operations in patients with dialysis-dependent renal failure.

Authors:  M Frenken; A Krian
Journal:  Ann Thorac Surg       Date:  1999-09       Impact factor: 4.330

2.  [Coronary arterial revascularization in dialysis patients].

Authors:  S Manabe; M Sunamori; T Sakamoto; H Tanaka; N Ohshima; S Hasegawa; M Watanabe; T Yoshizaki
Journal:  Kyobu Geka       Date:  2000-09

3.  Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.

Authors:  E Ovrum; E A Holen; G Tangen; F Brosstad; M Abdelnoor; M A Ringdal; R Oystese; R Istad
Journal:  Ann Thorac Surg       Date:  1995-08       Impact factor: 4.330

4.  Coronary artery bypass grafting in patients on chronic hemodialysis: surgical outcome in diabetic nephropathy versus nondiabetic nephropathy patients.

Authors:  Y Hosoda; T Yamamoto; K Takazawa; M Yamasaki; S Yamamoto; I Hayashi; K Kudoh
Journal:  Ann Thorac Surg       Date:  2001-02       Impact factor: 4.330

5.  Coronary artery bypass grafting in dialysis patients.

Authors:  Y Nakayama; R Sakata; M Ura; T A Miyamoto
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

6.  Cardiac operations in patients with end-stage renal disease.

Authors:  T K Kaul; B L Fields; M A Reddy; D R Kahn
Journal:  Ann Thorac Surg       Date:  1994-03       Impact factor: 4.330

7.  Internal mammary artery revascularization in the patient on long-term renal dialysis.

Authors:  B P Blakeman; H J Sullivan; B K Foy; P A Sobotka; R Pifarre
Journal:  Ann Thorac Surg       Date:  1990-11       Impact factor: 4.330

8.  Early and long-term results of coronary artery bypass grafting in dialysis patients.

Authors:  D L Franga; J M Kratz; A J Crumbley; J L Zellner; M R Stroud; F A Crawford
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

9.  Coronary artery bypass grafting in patients with dialysis-dependent renal failure.

Authors:  C H Owen; R G Cummings; T L Sell; S J Schwab; R H Jones; D D Glower
Journal:  Ann Thorac Surg       Date:  1994-12       Impact factor: 4.330

10.  Coronary artery bypass grafting in dialysis patients.

Authors:  W G Marshall; N P Rossi; R L Meng; T Wedige-Stecher
Journal:  Ann Thorac Surg       Date:  1986-12       Impact factor: 4.330

View more
  1 in total

Review 1.  Revascularization options in patients with chronic kidney disease.

Authors:  Guha Ashrith; MacArthur A Elayda; James M Wilson
Journal:  Tex Heart Inst J       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.